Delivery Order SPE2DB20D6035-SPE2DB24FD1SW
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,556,651 units of 0.3 mg epinephrine auto-injectors. The $2,903.70 contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,311,054 units of Epinephrine 0.3 mg auto-injectors. The potential value of the contract is $1,794.36, with a completion date of January 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The order, valued at $5,748.24, has a completion date of February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical product to a location in Conshohocken, Pennsylvania. This delivery order is part of a larger...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,652,889 units of Epinephrine 0.3 mg auto-injector 2s. The contract is valued at $8,098.21 and has a completion date of February 14, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The delivery order, valued at $1,045.37, has a completion date of March 1, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and is not a set-aside contract. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,265,621 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The $1,291.00 delivery order is part of a larger, open-ended contract with DLA Troop Support Medical to supply pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside designation was used for this award, which is...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,259,971 units of Epinephrine 0.3 mg auto-injector 2-packs. The $1,068.63 contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00, that...
- The U.S. Defense Logistics Agency (DLA) has awarded a $8,889.51 firm fixed price delivery order (SPE2DB22D1106|SPE2DB24FEKD8) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 4,564,185,884 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The delivery order, which does not have a set-aside designation, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp serves as the prime contractor for this award and holds a larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,471,888 units of epinephrine 0.3 mg auto-injectors. The contract has a potential value of $1,521.01 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical products from its corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The $6,185.31 contract has a completion date of January 3, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceutical products and medical supplies to support DLA Troop Support Medical facilities. This delivery order is part of Amerisourcebergen's broader...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB24FD1SWDelivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,609,507 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The contract has a potential value of $2,990.60 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will perform the work at its Corporate Office division located in Conshohocken, Pennsylvania. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies in support of the Department of Defense's military treatment programs and facilities worldwide. No set-aside designations were used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 2/9/24 |